Diagnosing AL and ATTR amyloid cardiomyopathy: a multidisciplinary approach
Amyloidosis with cardiac involvement is a fatal disease leading to progressive heart failure. The most common forms of amyloidosis with cardiac involvement are light chain (AL) and transthyretin (ATTR) amyloidosis. To allow effective specific treatment for both forms, precise and early diagnosis is...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 October 2024
|
| In: |
Journal of Clinical Medicine
Year: 2024, Volume: 13, Issue: 19, Pages: 1-12 |
| ISSN: | 2077-0383 |
| DOI: | 10.3390/jcm13195873 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/jcm13195873 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2077-0383/13/19/5873 
|
| Author Notes: | Fabian aus dem Siepen and Timon Hansen |
| Summary: | Amyloidosis with cardiac involvement is a fatal disease leading to progressive heart failure. The most common forms of amyloidosis with cardiac involvement are light chain (AL) and transthyretin (ATTR) amyloidosis. To allow effective specific treatment for both forms, precise and early diagnosis is important. This review focuses on diagnostic approaches for AL and ATTR amyloidosis with cardiac involvement, including different strategies, the role of imaging and biomarkers and possible pitfalls. |
|---|---|
| Item Description: | Gesehen am 27.03.2025 |
| Physical Description: | Online Resource |
| ISSN: | 2077-0383 |
| DOI: | 10.3390/jcm13195873 |